COMMUNIQUÉS West-GlobeNewswire

Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem
25/02/2026
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“STSS” or the “Company”) (NASDAQ: STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. (“The Tie”), the [...]
HealthEdge® GuidingCare Launches Decision Intelligence Ecosystem with Anterior, Latitude Health and Case Health AI
25/02/2026
Integrations with leading clinical AI solutions give health plans access to best-in-class decision-making capabilities to transform utilization management BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- HealthEdge® , the [...]
RAMSAY SANTE : résultats semestriels à fin décembre 2025
25/02/2026
COMMUNIQUÉ DE PRESSE Paris, le 25 février 2026 Résultats semestriels à fin décembre 2025 Une croissance portée par une offre de qualité et une rentabilité opérationnelle soutenue par des gains de productivité Des [...]
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026
25/02/2026
CLEARWATER, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
25/02/2026
- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company’s ambitions to expand its commercialisation activities and advance its innovation agenda DUBLIN [...]
Johns Hopkins Health Plans Seeks Sponsors for Fifth Annual Healthy Drives Golf Tournament
25/02/2026
Proceeds Benefit United Way of Central Maryland HANOVER, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Swing into action and support your greater Maryland community. Johns Hopkins Health Plans invites local businesses and [...]
The Developing Doctor Releases New Book on Managing High-Functioning Anxiety
25/02/2026
"How To Relax Without Losing Your Edge" by Dr. Ben Reinking Offers a Modern Guide for Ambitious Professionals Iowa City, IOWA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- IOWA CITY, IA — High-functioning anxiety is often masked [...]
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
25/02/2026
The SPARK NS Translational Research Program now includes 22 projects that are collectively eligible for up to $44 million in funding and support for drug development MENLO PARK, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE [...]
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
25/02/2026
MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative cell therapy for life-threatening rare pediatric and chronic aging-related [...]
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
25/02/2026
REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it [...]
Baba Emerges from Stealth with Over $6.5 Million in Seed Funding to Expand Medicare-Covered Patient Advocacy for Older Adults
25/02/2026
Public debut includes Medicare- and Medicare Advantage-covered advocacy model and forthcoming Johns Hopkins clinical study NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Baba , a Medicare- and Medicare Advantage-covered [...]
RAMSAY SANTE : Half-year results at the end of December 2025
25/02/2026
PRESS RELEASE Paris, 25 th February 2026 Half-year results at the end of December 2025 Quality offering driving revenue growth, with continued efficiency supporting operational profitability Public funding to mitigate [...]
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
25/02/2026
In Q4-2025 the Company generated ~$400K in Operating Cash Flow, and Adjusted EBITDA of close to $1M NEW HAVEN, Conn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO [...]
Genmab to Participate in Upcoming Investor Conferences
25/02/2026
Media Release COPENHAGEN, Denmark; February 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that members of its E xecutive Committee will participat e in fireside chats at the following investor conferences in March [...]
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
25/02/2026
PRINCETON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation
25/02/2026
CEO, Brad Hauser, discusses building clinical credibility through rigorous science and peer-reviewed engagement THE WOODLANDS, TX, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or [...]
Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes
25/02/2026
Partnership will leverage Vivtex’s proprietary technologies built to identify optimal oral formulations for peptide and protein therapeutics with improved bioavailability Novo Nordisk will lead global development and [...]
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer
25/02/2026
Pharmaceutical veteran with extensive late-stage development and commercial experience to lead Rivus as it advances its pipeline of oral medicines that leverage energy expenditure for the treatment of MASH, obesity, and [...]
Prime Medicine to Participate in Upcoming Investor Conferences
25/02/2026
CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]

Pages